Skip to main content

Stanley-Laman Group, Ltd.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1601489 Berwyn, PA

Position in NBIX

as of Mar 31, 2026 · filed Apr 16, 2026
Position Value
$3,629,305
-$287,755 QoQ
Shares Held
27,549
-0.2% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Stanley-Laman Group, Ltd. holds $10,749,304 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (33.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
27,549 $3,629,305

All Filings in NBIX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,629,305 27,549
2025-12-31 $3,917,060 27,618
2025-09-30 $3,559,194 25,354
2025-06-30 $5,344,464 42,521
2025-03-31 $3,612,085 32,659
2024-12-31 $5,754,567 42,158
2024-09-30 $4,324,321 37,531
2024-06-30 $3,778,077 27,443